Sensidose is a pharmaceutical company. The company has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The company's product portfolio includes a number of brands and drugs intended for the treatment of, for example, Parkinson's. The main operations are in the Nordic region.

Quotes for Sensidose Aktiebolag

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Jack Spira

Chairperson of the Board

  • Kathrine Gamborg Andreassen

Board

  • Jostein Davidsen
  • Lars Hjarrand
  • Tony Brejke

Largest Owners

Name Capital % Votes % Date
Navamedic ASA 96,33 96,33 2023-09-27
Avanza Pension 0,70 0,70 2023-09-27
Nevada Konsult AB 0,32 0,32 2023-09-27
Ann-Charlotte Parker 0,22 0,22 2023-09-27
Viola Vitalis AB 0,22 0,22 2023-09-27
Lundbergs Textil AB 0,16 0,16 2023-09-27
Harriet Meyerson 0,14 0,14 2023-09-27
Johan Sivander 0,12 0,12 2023-09-27
Lars Perols 0,11 0,11 2023-09-27
Jan Berg 0,10 0,10 2023-09-27

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream